A novel anti-androgen candidate galeterone acts by targeting USP12, a deubiquitinating enzyme that controls prostate cancer growth and survival

作者:McClurg U; Dransfield D; Namdev N; Jacoby D; Chit N; Nakjang S; Edwards J; McCracken S; Robson C
来源:28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 2016-11-29 to 2016-12-02.
  • 出版日期2016-12